Croucher PI - Search Results

1

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.

Lawson MA, McDonald MM, Kovacic N, Hua Khoo W, Terry RL, Down J, Kaplan W, Paton-Hough J, Fellows C, Pettitt JA, Neil Dear T, Van Valckenborgh E, Baldock PA, Rogers MJ, Eaton CL, Vanderkerken K, Pettit AR, Quinn JM, Zannettino AC, Phan TG, Croucher PI. Lawson MA, et al. Among authors: croucher pi. Nat Commun. 2015 Dec 3;6:8983. doi: 10.1038/ncomms9983. Nat Commun. 2015. PMID: 26632274 Free PMC article.

2

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

Shipman CM, Rogers MJ, Apperley JF, Russell RG, Croucher PI. Shipman CM, et al. Among authors: croucher pi. Br J Haematol. 1997 Sep;98(3):665-72. doi: 10.1046/j.1365-2141.1997.2713086.x. Br J Haematol. 1997. PMID: 9332325 Free article.

3

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.

Shipman CM, Croucher PI, Russell RG, Helfrich MH, Rogers MJ. Shipman CM, et al. Among authors: croucher pi. Cancer Res. 1998 Dec 1;58(23):5294-7. Cancer Res. 1998. PMID: 9850051

4

Anti-tumour activity of bisphosphonates in human myeloma cells.

Shipman CM, Rogers MJ, Apperley JF, Graham R, Russell G, Croucher PI. Shipman CM, et al. Among authors: croucher pi. Leuk Lymphoma. 1998 Dec;32(1-2):129-38. doi: 10.3109/10428199809059253. Leuk Lymphoma. 1998. PMID: 10037008 Review.

5

The pharmacology of bisphosphonates and new insights into their mechanisms of action.

Russell RG, Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Croucher PI, Shipman C, Fleisch HA. Russell RG, et al. Among authors: croucher pi. J Bone Miner Res. 1999 Oct;14 Suppl 2:53-65. doi: 10.1002/jbmr.5650140212. J Bone Miner Res. 1999. PMID: 10510215 Free article. Review.

6

Bisphosphonates: pharmacology, mechanisms of action and clinical uses.

Russell RG, Croucher PI, Rogers MJ. Russell RG, et al. Among authors: croucher pi. Osteoporos Int. 1999;9 Suppl 2:S66-80. doi: 10.1007/pl00004164. Osteoporos Int. 1999. PMID: 10525729 Review. No abstract available.

7

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.

Shipman CM, Vanderkerken K, Rogers MJ, Lippitt JM, Asosingh K, Hughes DE, Van Camp B, Russell RG, Croucher PI. Shipman CM, et al. Among authors: croucher pi. Br J Haematol. 2000 Oct;111(1):283-6. doi: 10.1046/j.1365-2141.2000.02310.x. Br J Haematol. 2000. PMID: 11091214 Free article.

8

Bisphosphonates--mechanisms of action in multiple myeloma.

Shipman CM, Rogers MJ, Vanderkerken K, Van Camp B, Graham R, Russell G, Croucher PI. Shipman CM, et al. Among authors: croucher pi. Acta Oncol. 2000;39(7):829-35. doi: 10.1080/028418600750063587. Acta Oncol. 2000. PMID: 11145441

9

In vivo homing and differentiation characteristics of mature (CD45-) and immature (CD45+) 5T multiple myeloma cells.

Asosingh K, De Raeve H, Croucher P, Goes E, Van Riet I, Van Camp B, Vanderkerken K. Asosingh K, et al. Exp Hematol. 2001 Jan;29(1):77-84. doi: 10.1016/s0301-472x(00)00625-1. Exp Hematol. 2001. PMID: 11164108 Free article.

10

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

Holen I, Croucher PI, Hamdy FC, Eaton CL. Holen I, et al. Among authors: croucher pi. Cancer Res. 2002 Mar 15;62(6):1619-23. Cancer Res. 2002. PMID: 11912131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters